Merck chair looks back over 40-year career at company

As Merck ($MRK) Chairman Richard Clark (photo) prepares to retire, a phillyBurbs profile traces his career at the drugmaker from quality control manager at West Point to the company helm. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.